Total medical devices industry deals worth $7.3bn were announced globally for January 2022, with the $1.6bn acquisition of Apria being the sector’s biggest investment, according to GlobalData’s deals database.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 83.6% over the previous month of $44.3bn and a drop of 58.1% when compared with the last 12-month average of $17.34bn.
In terms of number of deals, the sector saw a rise of 4.84% with 195 deals in January 2022 when compared to the last 12-month average of 186 deals.
In value terms, North America led the activity with deals worth $4.7bn in January 2022.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDatamedical devices industry deals in January 2022: Top deals
The top five deals accounted for 57.6% of the overall value during January 2022.
The combined value of the top five deals stood at $4.18bn, against the overall value of $7.3bn recorded for the month.
The top five medical devices industry deals of January 2022 tracked by GlobalData were:
1) Owens & Minor $1.6bn acquisition deal with Apria
2) The $1.26bn private equity of 70% stake in Biofarma by Ardian Holding
3) Sema4 OpCo $623m acquisition deal with GeneDX
4) The $450m acquisition of Triad Life Sciences by ConvaTec Group
5) Casdin Capital and Viking Global Investors $250m private equity deal with Fluidigm
